Nine triterpene acids, viz., six of the ursane type, ursolic acid (1), corosolic acid (2), 3-epicorosolic acid (3), pomolic acid (4), tormentic acid (5) and hyptadienic acid (6), and three of the oleanane type, oleanolic acid (7), augustic acid (8) and 3-epimaslinic acid (9), among which 1 constituted the most predominant triterpene acid, were isolated and identified from ethanol extracts of the leaves of red perilla [Perilla frutescens (L.) Britton var. acuta Kudo] and green perilla [P. frutescens (L.) Britton var. acuta Kudo forma viridis Makino]. These eight compounds, 1, 2, 4-9, were evaluated for their inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation (1 g/ear) in mice. All the compounds tested showed a marked anti-inflammatory effect, with a 50% inhibitory dose (ID 50 ) of 0.09-0.3 mg per ear. In addition, an evaluation against the Epstein-Barr virus early antigen (EBV-EA) activation induced by TPA showed five compounds, 1-3, 5 and 9, with a potent inhibitory effect on EBV-EA induction (91-93% inhibition at 1 Â 10 3 mol ratio/TPA). Furthermore, compound 5 exhibited strong antitumor-promoting activity in an in vivo two-stage carcinogenesis test of mouse tumor by using 7,12-dimethylbenz(a)anthracene (DMBA) as an initiator and TPA as a promoter. have been reported as anti-inflammatory and antiallergic substances, and luteolin as an anti-inflammatory 3) and antitumor-promoting substance 4) in perilla leaves and seeds. A glycoprotein with a molecular mass of 6.0 kDa has been isolated and characterized from the hot-water extract of perilla leaves as an inhibitor against mast cell degranulation and hyaluronidase activity.
tion has recently been devoted to the anti-allergic, antiinflammatory, and antitumor-promoting substances in perilla plants. Rosmarinic acid 1) and -linolenic acid 2) have been reported as anti-inflammatory and antiallergic substances, and luteolin as an anti-inflammatory 3) and antitumor-promoting substance 4) in perilla leaves and seeds. A glycoprotein with a molecular mass of 6.0 kDa has been isolated and characterized from the hot-water extract of perilla leaves as an inhibitor against mast cell degranulation and hyaluronidase activity. 5) Since no systematic work has so far been reported on the lipophilic constituents of perilla leaves with potential biological activities, we were particularly interested in examining these compounds for their potential antitumor-promoting and anti-inflammatory activities. We report in this paper the isolation and identification of nine triterpene carboxylic acids (1) (2) (3) (4) (5) (6) (7) (8) (9) from the ethanol (EtOH) extracts of red and green perilla leaves and their inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice, and on the Epstein-Barr virus early antigen (EBV-EA) activation induced by TPA. In addition, we report the inhibitory effect of tormentic acid (5) on in vivo two-stage mouse skin carcinognenesis.
Materials and Methods
General experimental procedures. Nuclear magnetic resonance (NMR) spectra were recorded with a Jeol LA-500 spectrometer at 500 MHz ( 1 H-NMR) and 125 MHz ( 13 C-NMR). Electron-impact mass spectra (EIMS) were recorded by a Jeol JMS-GC mate spectrometer (70 eV) with a direct inlet system. Analytical thin-layer chromatography (TLC) on silica gel (silica gel F 254 , Merck;
y To whom correspondence should be addressed. Fax: +81-3-3293-7572; E-mail: akihisa@chem.cst. nihon-u.ac.jp Abbreviations: DMBA, 7,12-dimethylbenz(a)anthracene; EBV-EA, Epstein-Barr virus early antigen; EIMS, electron-impact mass spectra; EtOAc, ethyl acetate; EtOH, ethanol; HPLC, high-performance liquid chromatography; MeOH, methanol; NMR, nuclear magnetic resonance; PKC, protein kinase C; TPA, 12-O-tetradecanoylphorbol-13-acetate 10 Â 10 cm) was developed with n-hexane-ethyl acetate (EtOAc; 2 Extraction and isolation. Red perilla: Red perilla leaves (850 g) were oven dried, and the dried and pulverized leaves (111 g) were extracted three times at room temperature for 3 days each with EtOH to give an extract (7.0 g). This EtOH extract was partitioned between CHCl 3 -H 2 O (1:1, v/v) to give a CHCl 3 -soluble fraction (3.7 g ). This CHCl 3 fraction was chromatographed in a silica gel (100 g) column, eluting with a stepwise gradient of n-hexane-EtOAc [1:0 (0.4 l), 9:1 (2.6 l), 4:1 (1.9 l), 1:1 (1.0 l), 0:1 (1.8 l)]. n-HexaneEtOAc (4:1) eluted a fraction (313 mg; fraction A; R f value by TLC, 0.40), and n-hexane-EtOAc (1:1) eluted a fraction (607 mg; fraction B; R f value by TLC, 0.38). Fraction A was a mixture of ursolic acid (1) and oleanolic acid (7) in a ratio of 68:32 as determined by HPLC. Fraction B was subjected to preparative HPLC which yielded 1 (264.8 mg, t R 41.5 min), corosolic acid (2; 11.9 mg, t R 20.4 min), 3-epicorosolic acid (3; 2.4 mg, t R 16.3 min), pomolic acid (4; 13.4 mg, t R 9.3 min), tormentic acid (5; 49.3 mg, t R 5.8 min), hyptadienic acid (6; 16.2 mg, t R 11.0 min), 7 (46.3 mg, t R 39.2 min), augustic acid (8; 15.8 mg, t R 18.5 min), and 3-epimaslinic acid (9; 5.1 mg, t R 14.5 min). Green perilla: Green perilla leaves (1280 g) were dried and pulverized (171 g), and extraction with EtOH in the manner just described gave an extract (7.8 g Animals. Specific pathogen-free female ICR mice were obtained from Japan SLC (Shizuoka, Japan). The animals were housed, five per polycarbonate cage, in an air-conditioned specific pathogen-free room at 24 AE 2 C. Food and water were available ad libitum.
Assay of TPA-induced ear edema inflammation in mice. TPA (1 nM) dissolved in acetone (20 l) was applied to the right ear of mice by means of a micropipette. A volume of 10 l was delivered to both the inner and outer surfaces of the ear. The samples or their vehicle, MeOH-CHCl 3 -H 2 O (2:1:1, v/v/v; 20 l), as a control, were topically applied about 30 min before the TPA treatment. Ear thickness was determined with a pocket thickness gauge with a range of 0-9 mm, graduated at 0.01 mm intervals and modified so that the contact surface area was increased to reduce the loading, which was applied to the tip of the ear. inhibitory ratio (%)
Each value was the mean of individual determinations from 5 mice. The 50% inhibitory dose (ID 50 ) values were determined by the method of probit-graphic interpolation for four dose levels. Details of the in vivo anti-inflammatory test have been described previously. 17) Statistical analysis. A statistical analysis was carried out by Student's t-test.
In vitro EBV-EA activation experiment. The inhibition of EBV-EA activation was assayed by using Raji cells (EBV genome-carrying human lymphoblastoid cells; non-producer type) which had been cultivated in a 10% fetal bovine serum RPMI-1640 medium (Sigma, St. Louis, MO, USA). The Raji indicator cells (1 Â 10 6 cells/ml) were incubated in 1 ml of a medium containing 4 mM n-butyric acid as an inducer, 32 pM of TPA (20 ng/ ml in dimethyl sulfoxide), and a known amount (32, 16, 3.2 or 0.32 nmol) of the test compound at 37 C in a CO 2 incubator. After 48 h, the cell suspension was centri-fuged at 1000 r.p.m. for 10 min, and the supernatant was removed. The activated cells were stained with high-titer EBV-EA-positive sera from nasopharyngeal carcinoma patients, and the conventional indirect immunofluorescence technique was employed for detection. In each assay, at least 500 cells were counted, and the experiments were conducted three times. The average extent of EA induction was determined and compared with that from a positive control experiment in which the cells were treated with n-butyric acid plus TPA where by the extent of EA induction was ordinarily more than around 40%. The viability of the treated Raji cells was assayed by the Trypan Blue staining method. Details of the in vitro assay of EBV-EA induction have been reported previously. 18) In vivo two-stage carcinogenesis test on mouse skin papillomas. Each group of animals was composed of 15 mice housed five per cage and given water ad libitum. The back of each mouse was shaved with surgical clippers, and the mice were topically treated with DMBA (100 g, 390 nM) in acetone (0.1 ml) for the initiation treatment. One week after the initiation, papilloma formation was promoted twice a week by the application of TPA (1 g, 1.7 nM) in acetone (0.1 ml) to the skin. Group I received the TPA treatment alone, and group II received a topically applied test sample (85 nM) in acetone (0.1 ml) 1 h before each TPA treatment. The incidence and number of papillomas were observed and detected weekly for 18 weeks; only typical papillomas larger than about 1 mm in diameter were counted. Details of the in vivo two-stage carcinogenesis test have been reported previously.
19)

Results and Discussion
Triterpene acids were found to be abundantly present in the CHCl 3 -soluble lipophilic fractions from EtOH extracts of the leaves of red perilla and green perilla. Nine triterpene acids, viz., six ursanes (1-6) and three oleananes (7) (8) (9) , were identified in the fractions, among which, 1 [ca. 7% (red perilla) and ca. 6% (green perilla) of the EtOH extract] occurred as the most predominant triterpene acid constituent, this being followed by 7 (ca. 2% of the EtOH extract for both red and green perilla). Among the nine compounds (1-9) identified in this study, compounds 1, 5, and 7 have previously been detected in perilla leaves. 10, 20, 21) Eight triterpene acids, 1, 2, and 4-9, were evaluated with respect to their anti-inflammatory activity against TPA-induced inflammation in mice, and the inhibitory effects were compared with those of two commercially available anti-inflammatory drugs, indomethacin and hydrocortisone, as shown in Table 1 . All of the triterpene acids tested markedly inhibited the TPAinduced inflammation at 0.03-0.3 mg/ear of the 50% inhibitory dose, this being almost comparable with or more inhibitory than indomethacin (ID 50 value = 0.3 mg/ear). Compound 5 exhibited the strongest inhibitory effect among the others tested, its 50% inhibitory dose being comparable with that of hydrocortisone (ID 50 value = 0.03 mg/ear). The inhibitory effect against TPA-induced inflammation has been demonstrated to closely parallel that of the inhibition of tumor promotion in two-stage carcinogenesis initiated by DMBA and then by TPA, a well-known promoter, in a mouse skin model; 22) thus, the triterpene acids from perilla leaves might be expected to possess a high antitumor-promoting effect in the same animal model.
The inhibitory effect on EBV-EA activation induced by TPA was further examined as a preliminary evaluation of the potential antitumor-promoting activities of the nine triterpene acids; the results are shown in Table 1 , together with comparable data for -carotene, a vitamin A precursor that has been intensively studied in cancer chemoprevention by using animal models, 23) and for luteolin, 17, 24) rosmarinic acid (unpublished results) and -linolenic acid 25) which are known as the constituents of perilla and possess various pharmacological activities. [1] [2] [3] [4] 26, 27) Five compounds, 1-3, 5 and 9, among the nine compounds showed potent inhibitory effects, 91-93% inhibition of activation at a 1 Â 10 3 mol ratio/TPA, while preserving the high viability of Raji cells. The inhibitory effects of compounds 1-3, 5 and 9 were found to be almost equivalent to those of -carotene, rosmarinic acid, and -linolenic acid.
On the basis of these results, the inhibitory effect of compound 5 in a two-stage carcinogenesis test on mouse skin, using DMBA as an initiator and TPA as a promoter, was investigated. As shown in Fig. 2 , in the positive control group, which received treatment with DMBA and TPA, there was 100% incidence of papillomas within 11 weeks of promotion ( Fig. 2A; percentage of papilloma bearers). In the group treated with DMBA, TPA and compound 5, about 27%, 67%, and 87% of the mice bore papillomas after 10, 15, and 18 weeks of tumor promotion, respectively. These tumor-inhibitory effects were also seen as a reduction in the number of papillomas ( Fig. 2B ; number of papillomas per mouse) in the compound 5 treatment group. In the positive control group, 4.8 and 8.6 papillomas were formed per mouse after 10 and 18 weeks of promotion, respectively. In the group treated with DMBA, TPA and 5, only 1.4 and 4.5 papillomas were formed per mouse after the same respective periods.
Compound 5 has thus been demonstrated in this study to possess inhibitory effects on TPA-induced ear inflammation and tumor promotion in mice. Similar observations have previously been reported on compounds 1 19, [28] [29] [30] and 7. 19, 28, 29) The antitumor-promoting potency of compounds 1, 5 and 7 can be understood from our hypothesis that the protein kinase C (PKC) signaling pathway would be involved in their inhibition. 23) Various pharmacological activities of compounds 1 and 7, 29, [31] [32] [33] anti-inflammatory activity 33) and inhibitory effects of mammalian DNA polymerases 34) of 5, and hypoglycemic effects of 2 35) have recently been reported. This study constitutes the first report on the anti-inflammatory and antitumor-promoting activities of compounds 2-4, 6, 8 and 9.
It can be concluded that the lipophilic triterpene acids from EtOH extracts of red perilla and green perilla leaves have potential importance from their cancer chemoprevention and anti-inflammatory activities. One week after initiation by a single topical application of DMBA (390 nmol), TPA (1.7 nmol) was applied twice weekly: A, percentage of mice with papillomas; B, average number of papillomas per mouse. TPA control alone; TPA + 85 nmol of compound 5. After 18 weeks of promotion, a significant difference in the number of papillomas per mouse between the groups treated with compound 5 and the control group was evident (P < 0:05).
